Korean Skin Treatments During Pregnancy or Breastfeeding: What Clinics Will and Will Not Do - A Complete Guide

Screening paperwork, not the device list, is where a pregnancy or breastfeeding plan is actually decided. Photo: Sasun Bughdaryan / Unsplash
Quick answer Korean skin clinics treat pregnancy as a reason to defer elective dermatologic procedures rather than to modify them, so most energy-based and injectable treatments are postponed until after delivery. Breastfeeding is assessed separately and more permissively. Clinics usually continue hygiene-level care, topical review and photographic monitoring, and they will ask you to confirm your status in writing before any device is switched on.
In this guide
Why Korean clinics default to deferral
Korea now treats a very large volume of international dermatology patients. The Ministry of Health and Welfare reported 2,010,000 foreign patients in 2025, of whom 1,310,000 — 62.9% — were seen in dermatology, and 87.7% of treatment episodes took place at clinic-level institutions rather than hospitals [3]. That scale matters here for an unglamorous reason: a clinic seeing high throughput of elective cases has very little incentive to accept a case whose risk profile cannot be documented. Elective cosmetic dermatology has no clinical urgency, and the evidence base for performing it during pregnancy is built almost entirely on case reports and small series rather than controlled trials [1][2]. Faced with an unquantifiable risk and a treatment that can simply wait, most Korean clinics choose to wait. Expect deferral to be presented as policy rather than as a clinical judgement about you specifically.
What most clinics will still do
Deferral is not the same as being turned away at the door. In practice, Korean clinics generally continue with the parts of care that carry no device energy and no injectate. A consultation, skin analysis imaging and a written plan are usually still offered, which is useful if you intend to start a course after delivery and want a documented baseline. Basic hygiene-level facials and bland moisturising or barrier care are commonly continued. Clinics will also review the topical products you are already using and flag anything they consider unsuitable, which in practice most often concerns retinoids and some acne agents — an issue covered separately in our guide to acne treatment at Korean dermatology clinics. Some clinics will book the first post-delivery session at the consultation so that the course starts without a second trip.
What most clinics will decline outright
The declined list is broader than many patients expect, and it is largely consistent between clinics. Injectables — botulinum toxin, hyaluronic acid fillers and the various skin-booster categories — are normally refused, not because harm has been demonstrated but because it has not been studied in this population. MotherToBaby, the information service of the Organization of Teratology Information Specialists, notes that botulinum toxin is expected to remain at the injection site and has not been specifically studied in pregnancy or breastfeeding, and that limited research on dermal and lip fillers makes pausing injections a reasonable choice [4]. Body-contouring and anything requiring sedation or tumescent anaesthesia is declined. Medium and deep chemical peels are usually declined as well; Trivedi and colleagues advise that trichloroacetic and salicylic acid peels should be avoided or used with caution, while glycolic and lactic acid peels appeared generally safe in the cases reviewed [2].
Treatment category | During pregnancy | During breastfeeding | Why clinics take this position |
Consultation, imaging, written plan | Usually proceeds | Usually proceeds | No energy, no injectate, no absorption question |
Hygiene facial, barrier and moisturising care | Usually proceeds | Usually proceeds | Treated as skincare rather than a procedure |
Superficial glycolic or lactic acid peel | Case by case | Often proceeds | Reviewed cases suggested a reassuring profile [2] |
Trichloroacetic or salicylic acid peel | Generally declined | Case by case | Advised to be avoided or used with caution [2] |
Laser and light-based treatment | Generally deferred | Often proceeds | Evidence is reassuring but low-level [1][2] |
Botulinum toxin, fillers, skin boosters | Generally declined | Case by case, often declined | Not specifically studied in this population [4] |
Sclerotherapy | Declined in the first trimester and after week 36 | Not recommended | Explicit timing advice in the published review [2] |
Fat transfer, tumescent liposuction | Declined | Not recommended | Not recommended during lactation [2]; surgery best avoided [4] |
Where the laser evidence actually stands
Lasers are the category where clinic policy and published evidence diverge most visibly, so it is worth being precise. The largest synthesis available is a systematic review by Wilkerson and colleagues, which searched the literature from 1960 to 2017 and pooled 22 publications covering 380 pregnant women treated with a range of laser wavelengths across all trimesters. Apart from a single case of premature rupture of membranes that the authors described as questionably related to treatment, they reported no maternal or fetal morbidity or mortality, no premature labour and no identifiable fetal stress, and they concluded that cutaneous laser treatment during pregnancy appears safe for mother and fetus [1]. The authors also argue that laser physics predicts no fetal exposure from commonly used cutaneous devices, since the light does not penetrate anywhere near the uterus. The caveat is that this body of evidence is made up of case reports and case series, not trials. A Korean clinic declining an elective laser session during pregnancy is therefore not contradicting the literature; it is declining to act on low-level evidence for a treatment that is purely cosmetic and can be rescheduled. If you want to understand who would be holding the handpiece in the first place, see our guide on who actually performs laser treatment in Korea.
Where the real risk sits |
The documented hazard in this area is less about the device than about the setting. Non-medical premises cannot screen for pregnancy, cannot assess medication history and cannot manage an adverse reaction. If you are pregnant or breastfeeding and still considering any treatment, the venue question matters more than the machine name. This article is general information and not medical advice; decisions belong with your own obstetric and dermatology clinicians. |

When procedures are deferred, topical and barrier care is usually what the clinic works with instead. Photo: ibnu ihza / Unsplash
Breastfeeding is a different calculation
Patients often assume the two states are assessed together. They are not. The pregnancy question is whether anything can reach a fetus; the breastfeeding question is whether anything can reach milk in a meaningful quantity, and for most dermatologic procedures the honest answer is that very little is expected to. The published review treats lactation separately and is notably more permissive for procedural care, while still advising against fat transfer, sclerotherapy and tumescent liposuction during lactation [2]. In practice this means a Korean clinic that defers your laser course through pregnancy may be willing to begin it a few weeks after delivery even if you are still feeding, often with a request to express and discard milk around a session involving any systemic agent. The limiting factor is usually not the device but any oral medication the plan assumes, so ask whether the protocol depends on a prescription you would also be taking home — our note on taking prescription medication home from Korea covers the documentation side of that.
Anaesthetics, antiseptics and absorption
Most of the substantive discussion in a Korean consultation will not be about the laser at all. It will be about the topical anaesthetic cream applied beforehand, the antiseptic used on the skin and any oral analgesia offered afterwards. These are the components with a plausible absorption route, and they are also the components patients rarely think to ask about. Expect the clinic to reduce or eliminate topical anaesthetic for a pregnant patient, to shrink the treated area so that less product is needed, and to shorten occlusion time. Ask specifically what is in the numbing cream, what concentration is used, how long it stays on and over what surface area. Ask the same about any post-procedure antibiotic or steroid. A clinic that cannot answer those four questions quickly is a clinic that has not thought about your case, which is a more useful signal than any brochure.
How the screening conversation runs
Korean clinics screen for pregnancy on the intake form and again verbally before treatment, and you will usually be asked to sign a statement confirming your answer. Declaring a pregnancy does not void your consultation fee at most clinics, but it will change what is offered on the day, so build the trip around that possibility rather than discovering it at reception. Bring your obstetric records or at least your expected delivery date, since clinics anchor their deferral advice to gestational age. If you are already using prescription topicals, bring the packaging. Allergy and sensitivity screening runs in parallel and has its own limits, which we set out in the guide to patch testing and allergy screening before Korean skin treatments. One practical warning: do not let a coordinator rather than a clinician make the call. If the person telling you a treatment is fine is not the person who will perform it, ask to hear it from the clinician.
Planning a trip around pregnancy or feeding
If you are planning conception, the sequencing question is worth settling before you book. Courses that require several sessions over months are the ones most likely to be interrupted, and an interrupted course is not simply a paused one — spacing assumptions change and the clinic may want to reassess from the start. If there is any chance of pregnancy during the planned window, either compress the course or defer it. The same logic applies in reverse after delivery: ask the clinic to state in writing how many weeks postpartum it wants before the first session, because that figure varies between clinics and sometimes between clinicians in the same clinic. Where an oral agent is part of the plan, waiting periods can be long and are driven by the drug rather than the device, as our guide to isotretinoin and laser treatment timing in Korea sets out. Treat the whole thing as a scheduling problem with a medical constraint, not as a negotiation.
What the research says
Wilkerson and colleagues, 2019 — laser therapy during pregnancy
Design and population: a systematic review of medical databases across all specialties, covering reports published between 1960 and 2017, together with a review of legal cases. It pooled 22 publications describing a range of laser wavelengths used in 380 pregnant women across all trimesters. Results: other than one case of premature rupture of membranes which the authors characterised as questionably related to the treatment, no maternal or fetal morbidity or mortality, premature labour or identifiable fetal stress was reported; the authors concluded that cutaneous laser treatment during pregnancy appears safe for both mother and fetus [1]. Limitation: the included evidence is low-level, consisting of case reports and case series rather than controlled trials. What this means for you: the absence of signal across 380 reported cases is reassuring but it is not the same as demonstrated safety, which is precisely the gap a Korean clinic is managing when it defers an elective session rather than refusing to acknowledge the literature.
Trivedi and colleagues, 2017 — cosmetic procedures in pregnancy and lactation
Design and population: a review of the published literature on cosmetic procedures during pregnancy and lactation. Because controlled trials were lacking, the authors deliberately included case reports and case series. Results: minor procedures and glycolic and lactic acid peels were found to be generally safe; trichloroacetic and salicylic acid peels should be avoided or used with caution; botulinum toxin A may be safe although data are limited; sclerotherapy should be avoided in the first trimester and after week 36; laser and light therapies were generally considered safe for certain conditions; and fat transfer, sclerotherapy and tumescent liposuction were not recommended during lactation. The authors concluded that better evidence is needed but that preliminary evidence suggests good safety profiles for many commonly requested procedures [2]. Limitation: the same low evidence level, and findings are not procedure-specific enough to transfer to every device marketed in Korea. What this means for you: this is the source most likely to be sitting behind a clinic's written policy, so its category-by-category distinctions are the vocabulary to use when you ask why a given treatment is on or off the table.
Frequently asked questions
Will a Korean clinic treat me if I am in the first trimester?
For elective dermatologic procedures, usually not. Most clinics defer the whole pregnancy rather than distinguishing by trimester, and the first trimester is the period they are least willing to treat. Consultation, imaging and topical review generally still go ahead.
Is laser hair removal or pigmentation laser allowed during pregnancy in Korea?
The published evidence reports no maternal or fetal harm across 380 cases reviewed, and the authors concluded it appears safe [1]. Even so, most Korean clinics defer elective laser sessions until after delivery, because the evidence is low-level and the treatment is not time-critical.
Can I restart treatment while breastfeeding?
Often yes, and clinics are generally more permissive here than during pregnancy. The reviewed literature still advises against fat transfer, sclerotherapy and tumescent liposuction during lactation [2]. Ask whether the plan depends on any oral medication, since that is usually the limiting factor.
Do I have to disclose a pregnancy if I am only having a facial?
Yes. Disclose it regardless of how minor the treatment seems. Products, anaesthetic creams and antiseptics differ between protocols, and the clinic cannot adjust what it does not know. Withholding it also puts your consent on uncertain ground.
What if a clinic agrees to treat me when others declined?
Treat that as a question rather than an opportunity. Ask which clinician made the decision, on what basis, and what is written on the consent form. A willingness that cannot be explained in clinical terms is a reason for caution, not reassurance.
References
Wilkerson EC, Van Acker MM, Bloom BS, Goldberg DJ. Utilization of Laser Therapy During Pregnancy: A Systematic Review of the Maternal and Fetal Effects Reported From 1960 to 2017. Dermatologic Surgery, 2019;45(6):818-828. PMID 30998530.
Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. International Journal of Women's Dermatology, 2017;3(1):6-10. PMID 28492048.
Ministry of Health and Welfare, Republic of Korea. 2025 Foreign Patient Statistics: foreign patients exceed two million. Published 24 April 2026.
MotherToBaby, Organization of Teratology Information Specialists. Maintaining Your Glow: Navigating Cosmetic Procedures While Pregnant or Breastfeeding. Published 4 August 2023.
Related reading
About this guide. Korean Plastic Surgery Info is an independent information site for international patients considering treatment in Korea. We do not own, operate or represent any clinic, and we receive no commission or referral fee from any provider mentioned. This article summarises published literature and official sources as cited above and is general information, not medical advice. Decisions about treatment during pregnancy or breastfeeding should be made with your own obstetric and dermatology clinicians.



Comments